Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
IL-1 alpha | 100 | ng/mL | 0 | IL-9 | 42.0 | 67 | |||||
IL-6 | 100 | ug/mL | 0 | IL-9 | 45.0 | 58 | |||||
IL-17A | 100 | ng/mL | 0 | IL-9 | 1705.0 | 64 | |||||
EGF | 100 | ng/mL | 0 | IL-9 | 43.0 | 61 | |||||
IGF-I | 100 | ug/mL | 0 | IL-9 | 41.0 | 72 | |||||
Adiponectin | 5 | ng/mL | 0 | IL-9 | 63.0 | 65 | |||||
Leptin | 1 | ng/mL | 0 | IL-9 | 46.0 | 47 | |||||
Visfatin | 1 | ng/mL | 0 | IL-9 | 43.0 | 55 | |||||
Poly(I:C) | 2 | ug/mL | 0 | IL-9 | 41.5 | 66 | |||||
0 | IL2-Ra | 15.0 | 56 | ||||||||
RA2159 | 1 | IL2-Ra | 16.0 | 79 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | IL2-Ra | 18.0 | 77 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL2-Ra | 13.0 | 59 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL2-Ra | 15.0 | 65 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | IL2-Ra | 15.5 | 64 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | IL2-Ra | 14.0 | 53 | ||||
RA2159 | 1 | IL2-Ra | 17.0 | 59 | |||||||
N2586 | 1 | IL2-Ra | 12.0 | 63 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | IL2-Ra | 15.0 | 69 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | IL2-Ra | 15.0 | 74 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | IL2-Ra | 17.0 | 51 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL2-Ra | 19.0 | 39 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL2-Ra | 11.0 | 36 | ||||
N2586 | 1 | IL2-Ra | 18.0 | 39 | |||||||
0 | IL2-Ra | 18.0 | 57 |